US Stock MarketDetailed Quotes

HRTX Heron Therapeutics

Watchlist
  • 3.200
  • -0.050-1.54%
Close Jul 22 16:00 ET
  • 3.269
  • +0.069+2.15%
Post 19:08 ET
482.09MMarket Cap-5818P/E (TTM)

Heron Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Heron Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 7, 2024

Revenue(YoY)

34.67M

+17.07%
EPS(YoY)

-0.02

+92.59%
Analyst Rating

Strong Buy

Jul 22, 2024

Heron Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 36.925M--
--2024/Q2-- / 35.888M--
May 7, 20242024/Q134.670M / 32.975M--
Mar 12, 20242023/Q434.233M / 31.217M--
Nov 14, 20232023/Q331.434M / 31.833M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 36.925M--
--2024/Q2-- / 35.888M--
May 7, 20242024/Q134.670M / 32.975M--
Mar 12, 20242023/Q434.233M / 31.217M--
Nov 14, 20232023/Q331.434M / 31.833M--

Unlock Free Earnings Estimates

Heron Therapeutics Earnings Reports

  • Heron Therapeutics | 10-Q: Quarterly report

    May 7 08:09 ET

  • Heron Therapeutics | 10-K: Annual report

    Mar 12 16:19 ET

  • Heron Therapeutics: Q3 2023 Earnings Report

    Nov 14, 2023 16:15 ET

  • Heron Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 14, 2023 16:16 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 22, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg